The chapter discusses the development and significance of Neuralink, a company that is about to start implanting devices in humans. The speaker provides insights into Neuralink's technology, its first trial, and how it differs from its competitors. It also explores the potential life-changing impact of the technology and the interest from healthcare companies in this field.
Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek."
Hosted by Carol Massar and Tim Stenovec
Hear the show live at 3PM ET on WBBR 1130 AM New York, Bloomberg 106.1 FM Boston, Bloomberg 960 AM San Francisco, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 119, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio.
You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.
Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW
See omnystudio.com/listener for privacy information.